Charming Medical (MCTA) Common Equity (2024 - 2026)

Charming Medical has disclosed Common Equity across 3 years of filings, most recently posting $5.2 million for Q1 2026.

• In Q1 2026, Common Equity rose 10421.22% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 10421.22% YoY), while the FY2026 annual figure was $5.2 million, up 10421.22% from the prior year.
• Common Equity came in at $5.2 million for Q1 2026 at Charming Medical, up from $49243.0 in the prior quarter.
• In the past five years, Common Equity ranged from a high of $5.2 million in Q1 2026 to a low of -$1.1 million in Q1 2024.
• Average Common Equity over 3 years is $1.4 million, with a median of $49243.0 recorded in 2025.
• Year-over-year, Common Equity soared 104.3% in 2025 and surged 10421.22% in 2026.
• Over 3 years, Common Equity stood at -$1.1 million in 2024, then jumped by 104.3% to $49243.0 in 2025, then surged by 10421.22% to $5.2 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $5.2 million in Q1 2026, $49243.0 in Q1 2025, and -$1.1 million in Q1 2024.